StockData
LeMaitre Vascular Inc logo

LeMaitre Vascular Inc (LMAT) stock

LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$76.10−0.91 (-1.18%)

Close on Nov 17, 2026Market cap $1.74BP/E 26.7Yield 1.05%

LeMaitre Vascular EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

LeMaitre Vascular's EV/EBITDA was 16.4× on Nov 11, 2026, against 22.0× a year earlier. Over the last 5 years it ranged from 16.4× to 39.1×, with a median of 25.7×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202616.4×−5.1
2025Dec 31, 202521.4×−11.7
2024Dec 31, 202433.1×+5.8
2023Dec 29, 202327.4×+2.8
2022Dec 30, 202224.6×+4.1
2021Dec 31, 202120.5×−4.9
2020Dec 31, 202025.4×+0.4
2019Dec 31, 201925.0×+10.5
2018Dec 31, 201814.5×−11.8
2017Dec 29, 201726.3×+2.9
2016Dec 30, 201623.4×+3.7
2015Dec 31, 201519.7×+6.3
2014Dec 31, 201413.4×−3.8
2013Dec 31, 201317.2×+6.5
2012Dec 31, 201210.7×−10.5
2011Dec 30, 201121.2×−3.9
2010Dec 31, 201025.1×–

More LeMaitre Vascular figures

See a number that looks wrong?